unknown
Stage
1
Investors
About
Belyntic develops novel immunotherapies and vaccines that harness patients' T cell responses to fight infectious diseases and cancer using their proprietary T-Fender platform based on synthetic long peptides and AI-powered design.
Explore Belyntic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.